131 related articles for article (PubMed ID: 2159265)
1. [Combination chemotherapy of ifosfamide, cisplatin and vindesine for non-small cell lung cancer].
Itami S; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Fukutani H; Tabata M; Hirano A; Mizunuma N; Nakagawa K
Gan To Kagaku Ryoho; 1990 May; 17(5):1015-20. PubMed ID: 2159265
[TBL] [Abstract][Full Text] [Related]
2. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
3. [An early phase II trial combining cisplatin, carboplatin and vindesine in patients with inoperable non-small cell lung cancer].
Haneda H; Koizumi M; Hayashi T
Gan To Kagaku Ryoho; 2000 Feb; 27(2):227-31. PubMed ID: 10700892
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
[TBL] [Abstract][Full Text] [Related]
5. European experience with ifosfamide in non-small cell lung cancer.
Drings P
Semin Oncol; 1989 Feb; 16(1 Suppl 3):22-30. PubMed ID: 2539645
[TBL] [Abstract][Full Text] [Related]
6. [Cisplatin, ifosfamide and vindesine in the chemotherapy of squamous cell carcinoma of the lung].
Fujita A; Inoue Y; Sasaki H; Nakajima S; Sekine K; Honda R; Asakawa M; Suzuki A
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2283-7. PubMed ID: 1929449
[TBL] [Abstract][Full Text] [Related]
7. [Phase II study of a three-drug combination of ifosfamide, cisplatin and vindesine in non-small-cell lung cancer].
Ohnoshi T; Hiraki S; Ueoka H; Tamura T; Kawahara S; Yonei T; Yamashita H; Ishii J; Tamai M; Egawa T
Gan To Kagaku Ryoho; 1988 Jan; 15(1):115-9. PubMed ID: 2827585
[TBL] [Abstract][Full Text] [Related]
8. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
9. [Cisplatin, doxorubicin and vindesine in the treatment of advanced non-small cell lung cancer].
Akiyama J; Sato A; Honda K; Chida K; Watanabe T; Okano H; Okano A; Taniguchi M; Genma H; Aoki H
Gan To Kagaku Ryoho; 1991 Mar; 18(3):419-24. PubMed ID: 1848420
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tominaga K; Sakurai M; Suga J; Miyaoka H; Sano T; Keicho N
Jpn J Cancer Res; 1986 Aug; 77(8):782-9. PubMed ID: 3019976
[TBL] [Abstract][Full Text] [Related]
11. Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
Sculier JP; Lafitte JJ; Paesmans M; Thiriaux J; Alexopoulos CG; Baumöhl J; Schmerber J; Koumakis G; Florin MC; Zacharias C; Berghmans T; Mommen P; Ninane V; Klastersky J
Br J Cancer; 2000 Nov; 83(9):1128-35. PubMed ID: 11027424
[TBL] [Abstract][Full Text] [Related]
12. [Combination chemotherapy including cisplatinum, vindesine and mitomycin C for non-small cell lung cancer].
Hayashi Y; Kato M; Matsuura T; Yamada Y; Adachi S; Ito G; Yamamoto K; Takeuchi T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1455-60. PubMed ID: 2167632
[TBL] [Abstract][Full Text] [Related]
13. Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial.
Lorusso V; Gebbia V; Spada M; Guida M; Cassano G; Brunetti C; Germano D; Nettis G; Izzi G; Galetta D; Giampaglia M; Silvestris N; Colucci G
Oncol Rep; 2005 Dec; 14(6):1547-51. PubMed ID: 16273254
[TBL] [Abstract][Full Text] [Related]
14. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
Fujii M; Kiura K; Okabe K; Toki H; Kimura M
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2676-81. PubMed ID: 2820312
[TBL] [Abstract][Full Text] [Related]
15. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
[TBL] [Abstract][Full Text] [Related]
16. Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer.
Recchia F; Sica G; De Filippis S; Rea S; Frati L
Anticancer Res; 1997; 17(5B):3761-5. PubMed ID: 9427776
[TBL] [Abstract][Full Text] [Related]
17. [Randomized trial of cisplatin plus ifosfamide versus cisplatin plus vindesine for non-small cell lung cancer (NSCLC)].
Nakabayashi T; Miyamoto H; Fujikane T; Shimizu T; Yasuda S; Akita H; Sakai E; Onodera S; Ohsaki Y; Kawakami Y
Gan To Kagaku Ryoho; 1992 Jan; 19(1):61-7. PubMed ID: 1309633
[TBL] [Abstract][Full Text] [Related]
18. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H
Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
[TBL] [Abstract][Full Text] [Related]
19. [Phase II study of ifosfamide and vindesine combination of non-small cell lung cancer in elderly patients and patients with reduced renal function].
Fujii M; Segawa Y; Matsutomo S; Genba K
Gan To Kagaku Ryoho; 1990 May; 17(5):1021-5. PubMed ID: 2159266
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy with ifosfamide, mitomycin, and cisplatin in advanced non-small cell lung cancer.
Girón CG; Ordónez A; Jalón JI; Barón MG
Cancer Treat Rep; 1987 Sep; 71(9):851-3. PubMed ID: 3040245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
